Novartis CEO says it won't join weight-loss drug frenzy

The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…

First round of Medicare drug price negotiations nearing end

Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…